International Stem Cell (ISCO) Cash & Equivalents (2010 - 2026)
International Stem Cell's Cash & Equivalents came in at $1.09 million for Q2 2026, up 18.4% from $920,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell's Cash & Equivalents was $993,000, down 19.3% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $1.23 million in FY2024 (-22.5%), $1.59 million in FY2023 (+114.0%), $742,000 in FY2022 (+333.9%) and $171,000 in FY2021 (-75.2%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q1 2025.
- Year-over-year, Cash & Equivalents increased in two of the last seven quarters, with an average decline of 11.7%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2022 (growth of 333.9%), and the weakest in Q4 2021 (a decline of 75.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | International Stem Cell | 1.20 Mn | -2.77 Mn | 1.46 Mn | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Dec 31, 2025 | 993,000.00 |
| Sep 30, 2025 | 966,000.00 |
| Jun 30, 2025 | 920,000.00 |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 943,000.00 |
| Dec 31, 2022 | 742,000.00 |
| Sep 30, 2022 | 666,000.00 |
| Jun 30, 2022 | 586,000.00 |
| Mar 31, 2022 | 398,000.00 |
| Dec 31, 2021 | 171,000.00 |
| Sep 30, 2021 | 505,000.00 |
| Jun 30, 2021 | 750,000.00 |
API Access
International Stem Cell Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();